Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 21 Jan 2002 |
| Genmab, Oxford Glycosciences, Medarex and Genmab announce comprehensive campaign to Treat breast cancer | 9 Jan 2002 |
| Genmab, to present at the 2002 JP Morgan H&Q Healtcare Conference | 7 Jan 2002 |
| Genmab, to Present at the 2002 JP Morgan H&Q Healtcare Conference (correction) | 7 Jan 2002 |
| Genmab, appoints Rachel Gravesen | 17 Dec 2001 |